Alkermes ALKS
NASDAQ ALKS
$44.18 +0.70 (+1.61%)
At close: Oct 22, 2026 · 4:00 PM EDT

Alkermes (ALKS) Gains from Investment Securities (2014)

Updated

Analysis

Alkermes (ALKS) Gains from Investment Securities (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,139.57 Bn 1,108.15 Bn 19.71 Bn
2 Johnson & Johnson 634.50 Bn 554.36 Bn 17.30 Bn
3 AbbVie 500.91 Bn 474.02 Bn 12.70 Bn
4 Merck 355.88 Bn 310.26 Bn 12.21 Bn
5 Novartis Ag 300.26 Bn 264.25 Bn 11.24 Bn
6 Astrazeneca 263.05 Bn 236.74 Bn 12.86 Bn
7 Amgen 237.74 Bn 193.14 Bn 7.24 Bn
8 Gilead Sciences 194.00 Bn 168.19 Bn 6.22 Bn
9 Pfizer 170.20 Bn 116.85 Bn 10.94 Bn
10 Alkermes 7.23 Bn 4.36 Bn 397.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 14.27 Mn
Jun 30, 2014 15.30 Mn
API Access

Alkermes Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=ALKS&period=max&api_key=YOUR_API_KEY